Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · IEX Real-Time Price · USD
3.860
-0.050 (-1.28%)
At close: Apr 24, 2024, 4:00 PM
3.930
+0.070 (1.81%)
After-hours: Apr 24, 2024, 7:30 PM EDT
Relmada Therapeutics Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$26.00
Upside
+573.58%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Strong Buy Reiterates $26 | Strong Buy | Reiterates | $26 | +573.58% | Jun 15, 2023 |
| SVB Leerink | SVB Leerink | Buy Maintains $42 → $10 | Buy | Maintains | $42 → $10 | +159.07% | Jan 23, 2023 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $8 | Strong Buy → Hold | Downgrades | $8 | +107.25% | Oct 14, 2022 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 14, 2022 |
| Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 13, 2022 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $49 → $81 | Strong Buy | Maintains | $49 → $81 | +1,998.45% | Sep 23, 2022 |
| Guggenheim | Guggenheim | Strong Buy Maintains $50 → $60 | Strong Buy | Maintains | $50 → $60 | +1,454.40% | Sep 6, 2022 |
| Oppenheimer | Oppenheimer | Buy Maintains $75 → $64 | Buy | Maintains | $75 → $64 | +1,558.03% | May 9, 2022 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $69 → $53 | Strong Buy | Maintains | $69 → $53 | +1,273.06% | Mar 24, 2022 |
| SVB Leerink | SVB Leerink | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Dec 20, 2021 |
| Mizuho | Mizuho | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Nov 18, 2021 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Apr 21, 2020 |
| Jefferies | Jefferies | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Jan 27, 2020 |
| Guggenheim | Guggenheim | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 16, 2019 |